MGAM
JAZZ icon

McGowan Group Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

McGowan Group Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,226
Closed -$5.01M – 126
2025
Q2 		$5.01M Sell
47,226
-921
-2% -$100K 0.63% 35
2025
Q1 		$5.98M Sell
48,147
-847
-2% -$110K 0.79% 30
2024
Q4 		$6.03M Buy
+48,994
New +$5.77M 0.81% 30
2015
Q3 		– Sell
-2,075
Closed -$365K – 139
2015
Q2 		$365K Buy
+2,075
New +$373K 0.07% 105

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

McGowan Group Asset Management's JAZZ Position: Q3 2025 in Review

McGowan Group Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 47,226 shares — an estimated $5.01M sold.

McGowan Group Asset Management first reported a position in JAZZ in Q2 2015 and held it in 4 quarters. The position peaked at $6.03M in Q4 2024. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • McGowan Group Asset Management reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • McGowan Group Asset Management sold 47,226 Jazz Pharmaceuticals shares in Q3 2025, an estimated $5.01M.
  • McGowan Group Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • McGowan Group Asset Management's Jazz Pharmaceuticals position peaked at $6.03M in Q4 2024.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on McGowan Group Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.